CMS certification 523300
Childrens Hospital of Wisconsin
9000 W Wisconsin Ave, Milwaukee, WI 53226
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
1,091 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pediatrics | 238 |
| Physician Assistant | 66 |
| Psychologist | 37 |
| Audiologist | 35 |
| Pediatric Critical Care Medicine | 35 |
| Pediatric Cardiology | 32 |
| Pediatric Hematology-Oncology | 31 |
| Neonatal-Perinatal Medicine | 30 |
| Pediatric Gastroenterology | 29 |
| Neonatal | 27 |
| Pediatric Emergency Medicine | 27 |
| Pediatric Anesthesiology | 26 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $166,755
- 2020 $194,608
- 2021 $794,476
- 2022 $118,704
- 2023 $51,792
- 2024 $57,065
- 2025 $183,310
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $21,474 | 14 |
| Speaking, teaching and other services | $19,423 | 6 |
| Grants | $4,000 | 1 |
| Space rental and facility fees | $3,000 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Incyte Corporation | $131,313 | 46 |
| MED-EL Corporation | $18,180 | 1 |
| National Marrow Donor Program | $15,255 | 5 |
| Olympus Corporation of the Americas | $4,000 | 1 |
| Novartis Pharmaceuticals Corporation | $3,904 | 2 |
| Masimo Corporation | $3,234 | 12 |
| Siemens Medical Solutions USA, Inc. | $2,736 | 1 |
| Ortho-Clinical Diagnostics, Inc. | $2,432 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-H… Incyte Corporation | $115,305 |
| A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Seve… Incyte Corporation | $10,255 |
| realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLB… Incyte Corporation | $5,708 |
| BMN165-306 BioMarin Pharmaceutical Inc. | $2,197 |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research National Marrow Donor Program | $1,000 |
| A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocr… Novartis Pharmaceuticals Corporation | $904 |
| A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo Incyte Corporation | $45 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Childrens Hospital of Wisconsin
Does Childrens Hospital of Wisconsin have an emergency room?
Yes. CMS lists emergency services at Childrens Hospital of Wisconsin.
Does Childrens Hospital of Wisconsin receive money from drug and device companies?
Drug and device makers reported $183,310 in payments to Childrens Hospital of Wisconsin for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.